An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.

Authors :: Marra A
Santi A
Pucciarini A
Venanzi A
De Carolis L
Zaja F
Ascani S
Canzonieri V
Ballanti S
Falini B
Tiacci E
Source :: American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 497-501. Date of Electronic Publication: 2024 Jan 24.
Publication Year :: 2024
Abstract: Distinct outcomes of BRAF inhibition in BRAF-mutated hairy cell neoplasms with wild-type or mutant TP53, and alternative strategies to overcome mutant TP53.<br /> (© 2024 Wiley Periodicals LLC.)

Subjects :: Humans
Precision Medicine
Mutation
Proto-Oncogene Proteins B-raf genetics
Neoplasms

Full Text Access

Tools